JF
INDV icon

Jump Financial’s Indivior Pharmaceuticals INDV Stock Holding History

Jump Financial’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Buy
70,430
+25,615
+57% +$929K 0.02% 742
2026
Q1 		$1.37M Buy
+44,815
New +$1.48M 0.02% 803
2025
Q3 		– Sell
-186,418
Closed -$2.75M – 1994
2025
Q2 		$2.75M Buy
+186,418
New +$2.17M 0.03% 619
2024
Q3 		– Sell
-11,098
Closed -$179K – 1864
2024
Q2 		$179K Buy
+11,098
New +$200K ﹤0.01% 1576

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's INDV Position: Q2 2026 in Review

Jump Financial increased its Indivior Pharmaceuticals (INDV) stake by 57% in Q2 2026, buying an estimated $929K and bringing the position to 70,430 shares worth $2.89M. The position accounts for 0.02% of the portfolio, ranked #742.

Jump Financial first reported a position in INDV in Q2 2024 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Jump Financial held 70,430 shares of Indivior Pharmaceuticals worth $2.89M as of Q2 2026.
  • Jump Financial bought 25,615 Indivior Pharmaceuticals shares in Q2 2026, an estimated $929K.
  • Indivior Pharmaceuticals made up 0.02% of Jump Financial's portfolio in Q2 2026, its #742 holding.
  • Jump Financial first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.